{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreih34mklfmcxyhq7djymm7zpzdtnss2f67ahyvc7zqwpb53ezj44p4",
    "uri": "at://did:plc:vv5cq7qjnr2fd5ytohsyyegf/app.bsky.feed.post/3mnc4ztniskt2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreifwbmxd7p6mj7td6ptaku24pux6z2qlan7xhcidyv2pahwxkb2ibi"
    },
    "mimeType": "image/jpeg",
    "size": 262778
  },
  "path": "/2026/06/a-new-drug-just-cleared-hepatitis-b-in-1-in-5-patients/",
  "publishedAt": "2026-06-01T00:00:22.000Z",
  "site": "https://www.optimistdaily.com",
  "tags": [
    "Evergreen",
    "Health",
    "Medicine",
    "Science",
    "Technology",
    "Trending",
    "bepirovirsen clinical trial",
    "chronic hepatitis B treatment",
    "functional cure hepatitis B",
    "health",
    "hepatitis B breakthrough 2026",
    "hepatitis B cure",
    "Liver Disease",
    "Research",
    "science",
    "A new drug just cleared hepatitis B in 1 in 5 patients",
    "The Optimist Daily: Making Solutions the News"
  ],
  "textContent": "BY THE OPTIMIST DAILY EDITORIAL TEAM A clinical trial published May 28 in the New England Journal of Medicine reports that a new drug called bepirovirsen achieved a functional cure in approximately one in five patients with chronic hepatitis B. That number matters. The current standard of care achieves a functional cure in around three […]\n\nThe post A new drug just cleared hepatitis B in 1 in 5 patients first appeared on The Optimist Daily: Making Solutions the News.",
  "title": "A new drug just cleared hepatitis B in 1 in 5 patients"
}